Dissolution characteristics of megaloporous tablets prepared with two kinds of matrix granules

Farmaco

Volumn 59, Issue 7, 2004, Pages 549-555

  Özgüney, Işik ^a   Ertan, Gökhan ^a   Güneri, Tamer ^a  

^a EGE UNIVERSITY   (Turkey)

Author keywords

Eudragits; Matrix granules; Megaloporous tablets; Naproxen sodium; Zero order release kinetic

Indexed keywords

EUDRAGIT; NAPROXEN; POLYMER;

ARTICLE; CONTROLLED DRUG RELEASE; DRUG DOSAGE FORM; DRUG FORMULATION; DRUG RELEASE; DRUG SOLUBILITY; MATRIX TABLET; POROSITY; PRESSURE; REACTION TIME; TABLET COMPRESSION; TABLET FORMULATION;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CHEMISTRY, PHARMACEUTICAL; DELAYED-ACTION PREPARATIONS; DRUG DESIGN; NAPROXEN; PARTICLE SIZE; POLYMETHACRYLIC ACIDS; POROSITY; TABLETS;

EID: 3042568817     PISSN: 0014827X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.farmac.2004.03.011     Document Type: Article

References (28)

1. Marentete J.M., Grosser A.E. Modelling of the kinetics of drug release from a binary system. J. Pharm. Sci. 81:1992;318-320
2. Ertan G., Karasulu E., Raif D., Arici M., Güneri T. Release characteristics of implantable cylindrical polyethylene matrices. J. Pharm. Pharmacol. 49:1997;229-235
3. Sangalli M.E., Giunchedi P., Maggi L., Conte U., Gazzaniga A. Inert monolithic device with a central hole for constant drug release. Eur. J. Pharm. Biopharm. 40:1994;370-373
4. Sangalli M.E., Maroni A., Zema L., Cerea M., Conte U., Gazzaniga A. A study on the release mechanism of drugs from hydrophilic partially coated perforated matrices. II Farmaco. 58:2003;971-976
5. Karasulu H.Y., Ertan G. Different geometric shaped hydrogel theophylline tablets: statistical approach for estimating drug release. II Farmaco. 57:2002;939-945
6. Fassihi A.R. Continuous matrix formation for controlled drug release: compression of isotropic polymeric system. Int. J. Pharm. 34:1986;169-172
7. Martinez-Pacheco R., Vila-Jato J.L., Souto C., Pamos T. Controlled release of cephalexin from double-layer tablets containing small proportions of acrylic resins. Int. J. Pharm. 32:1986;99-102
8. De Haan P., Lerk C.F. The megaloporous system: a novel principle for zero-order drug delivery. I. In vitro and in vivo performance. Int. J. Pharm. 31:1986;15-24
9. De Haan P., Lerk C.F. The megaloporous system: a novel principle for zero-order drug delivery. II. A model for the mechanism of drug delivery. Int. J. Pharm. 34:1986;57-66
10. De Haan P., Lerk C.F. The effects of polymer content and distribution on drug release characteristics of the megaloporous system. Acta Pharm. Technol. 33:1987;149-153
11. De Haan P., Lerk C.F. Parameters affecting the rate of exposure of the drug containing phase in the megaloporous system. Acta Pharm. Technol. 34:1988;106-107
12. Van Der Veen C., Menger N.R., Lerk C.F. Factors affecting the release rate of a highly soluble drug from a programmed release megaloporous system. Eur. J. Pharm. Biopharm. 40:1994;77-80
13. Kuttel S., Mezei J., Racz I. Formulation of a controlled-release iron preparation. Pharm. Ind. 52:1990;121-123
14. Schwarz J.B., Simonelli A.P., Higuchi W.I. Drug release from wax matrices. I. Analysis of data with first order kinetics and with the diffusion-controlled model. J. Pharm. Sci. 57:1968;274-277
15. Peppas L.B., Peppas N.A. Solute and penetrant diffusion in swelling polymers. IX. The mechanism of drug release from pH-sensitive swelling controlled systems. J. Control. Release. 8:1989;267-274
16. Shah S.S., Kulkarni M.G., Mashelkar R.A. pH dependent zero-order release from glassy hydrogels: penetration vs. diffusion controlled. J. Control. Release. 15:1991;221-232
17. Bamba M., Puisieux J.P., Marty J.P., Carstensen J.T. Physical model for release of drug from gel forming sustained release preparations. Int. J. Pharm. 3:1979;87-92
18. Bamba M., Puisieux J.P., Marty J.P., Carstensen J.T. Release mechanisms in gel forming sustained release preparations. Int. J. Pharm. 2:1979;307-315
19. Krüger-Thiemer E., Eriksen S.P. Mathematical model of sustained release preparations and its analysis. J. Pharm. Sci. 55:1966;1249-1253
20. Robinson J.R., Eriksen S.P. Theoretical formulation of sustained-release dosage forms. J. Pharm. Sci. 55:1966;1254-1263
21. Robinson J.R., Eriksen S.P. Theoretical approach to sustained-release multiple-dose therapy: noncumulative attainment of desired blood level. J. Pharm. Sci. 59:1970;1796-1800
22. Dahl T., Ling T., Yee J., Bormeth A. Effects of various granulating systems on the bioavailability of naproxen sodium from polymeric matrix tablets. J. Pharm. Sci. 79:1990;389-392
23. Wanwimolruk S., Lipschitz S., Roberts M.S. Pharmacokinetics and bioavailability of Naprosyn CR 500 mg tablet, a new controlled-release formulation of naproxen, after single and multiple dosing. Int. J. Pharm. 75:1991;55-62
24. Gaston G. A double-blind, randomized, parallel-group study of the pharmacokinetics and on set of action of Naprelan in patients following oral surgery. Am. J. Orthoped. (Suppl):September (1996);37-41
25. Welling P.G., Dobrinska M.R. Robinson J.R. Sustained and Controlled Release Drug Delivery Systems. 1978;Marcel Dekker, New York and Basel
26. Tarimci N.M., Agabeyoglu I. Studies on sustained release. III. Matrix granules of sulfamethizole. Drug Dev. Ind. Pharm. 11:1985;2043-2056
27. Jack D.B. Handbook of Clinical Pharmacokinetik Data. 1994;Macmillan Publishers Ltd. Basingstoke
28. Ritschel W.A., Gangadharan B. Design and development of a theophylline peroral controlled-release unit dosage form. Pharm. Ind. 50:1988;355-359